Trial intelligence / Profile preview

Metronomic Capecitabine + Digoxin in Metastatic Breast Cancer

NCT01887288Phase 2Terminated

Sponsor
Western Regional Medical Center
Start
Apr 2013
Primary completion
Nov 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of digoxin in breast cancer, sponsored by Western Regional Medical Center. Started Apr 2013; status: terminated.

02

Drugs

digoxin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01887288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01887288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call